BIOSYNTHESIZE NANOPARTICLES AS ADVANCED NANOCARRIERS FOR TARGETED THERAPEUTIC INTERVENTIONS IN DISEASE MANAGEMENT

Authors

  • A JANNAT Atta-ur-Rahman School of Applied Biosciences, Discipline Biotechnology, National University of Sciences and Technology
  • K BALQEES Department of Chemistry, University of Agriculture Faisalabad, Punjab Pakistan
  • M HASNAIN Department of Biochemistry, Government College University Faisalabad, Punjab Pakistan
  • M ASHIQ Department of Biochemistry, University of Agriculture Faisalabad, Punjab Pakistan
  • F MUZAMMAL Department of Biochemistry, University of Agriculture Faisalabad, Punjab Pakistan
  • Z JAVAID Department of Biochemistry, University of Agriculture Faisalabad, Punjab Pakistan
  • Z SAEED Department of Biochemistry, University of Agriculture Faisalabad, Punjab Pakistan
  • MH BAIG Department of Medical Laboratory Technology, AHP, Government College University Faisalabad, Punjab Pakistan
  • T MUMTAZ Department of Biotechnology, University of Peshawar, Pakistan
  • U RAUF Department of Chemistry, Government College University Faisalabad, Punjab Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1152

Keywords:

Biosynthesized Nanoparticles, Advanced Nanocarriers, Controlled Release Systems, Biocompatibility, Therapeutic Interventions, Disease Management, Biogenic Nanoparticles, Tumor Targeting, Drug Encapsulation

Abstract

Biosynthesized nanoparticles have emerged as cutting-edge nanocarriers for targeted therapeutic interventions in illness management, transforming medication delivery and treatment techniques. These nanoparticles provide a biocompatible and sustainable substitute for conventional synthetic processes since they are made utilizing biological systems including fungi, bacteria, and plants. They are perfect candidates for precision medicine because of their innate capacity to lower toxicity and increase bioavailability. Because of their distinct surface characteristics, biosynthesized nanoparticles are easily functionalized with therapeutic drugs, allowing for targeted distribution to sick cells or certain organs while reducing off-target effects. Additionally, the large surface area-to-volume ratio and nanoscale size promote better cellular absorption and regulated drug release, enhancing therapeutic efficacy. These nanoparticles' natural origin lowers their immunogenicity and adverse response risk, which enhances patient outcomes even more. Biosynthesized nanoparticles have demonstrated great promise in cancer therapy, including the ability to target tumor cells specifically, carry chemotherapy medications, and even combine with imaging agents for theragnostic uses. They also show promise in improving therapy specificity and lowering adverse effects in other diseases like infectious diseases, cardiovascular ailments, and neurological disorders. This study covers the developments in biosynthesized nanoparticles as nanocarriers, highlighting their importance in altering illness management through tailored therapeutics while evaluating the limitations and future prospects for their clinical translation.

Downloads

Download data is not yet available.

References

Ahmed, S. F., Mofijur, M., Rafa, N., Chowdhury, A. T., Chowdhury, S., Nahrin, M., ... & Ong, H. C. (2022). Green approaches in synthesising nanomaterials for environmental nanobioremediation: Technological advancements, applications, benefits and challenges. Environmental Research, 204, 111967.

Albanese, A., Tang, P. S., & Chan, W. C. (2012). The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annual review of biomedical engineering, 14(1), 1-16.

Albrecht, M. A., Evans, C. W., & Raston, C. L. (2006). Green chemistry and the health implications of nanoparticles. Green chemistry, 8(5), 417-432.

Ameen, F., Alsamhary, K., Alabdullatif, J. A., & ALNadhari, S. (2021). A review on metal-based nanoparticles and their toxicity to beneficial soil bacteria and fungi. Ecotoxicology and Environmental Safety, 213, 112027.

Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., ... & Vora, L. (2022). Nanoparticle-based delivery systems for vaccines. Vaccines, 10(11), 1946.

Bharti, B., Kumar, R., Kumar, H., Li, H., Zha, X., & Ouyang, F. (2022). Advanced applications and current status of green nanotechnology in the environmental industry. In Green functionalized nanomaterials for environmental applications (pp. 303-340). Elsevier.

Bonneuil, C., Foyer, J., & Wynne, B. (2014). Genetic fallout in bio-cultural landscapes: Molecular imperialism and the cultural politics of (not) seeing transgenes in Mexico. Social Studies of Science, 44(6), 901-929.

Bose, S., Sarkar, N., & Banerjee, D. (2020). Controlled Delivery of Natural Medicinal Compounds from Tissue Engineering Scaffolds for Critical-Sized Bone Defect Repair. Available at SSRN 3708576.

Christy, P. N., Basha, S. K., Kumari, V. S., Bashir, A. K. H., Maaza, M., Kaviyarasu, K., ... & Ignacimuthu, S. (2020). Biopolymeric nanocomposite scaffolds for bone tissue engineering applications–A review. Journal of drug delivery science and technology, 55, 101452.

Das, S., Bhardwaj, A., & Pandey, L. M. (2021). Functionalized biogenic nanoparticles for use in emerging biomedical applications: a review. Current Nanomaterials, 6(2), 119-139.

Dos Santos, C. A., Seckler, M. M., Ingle, A. P., Gupta, I., Galdiero, S., Galdiero, M., ... & Rai, M. (2014). Silver nanoparticles: therapeutical uses, toxicity, and safety issues. Journal of Pharmaceutical Sciences, 103(7), 1931-1944.

Fathi-Achachelouei, M., Knopf-Marques, H., Ribeiro da Silva, C. E., Barthès, J., Bat, E., Tezcaner, A., & Vrana, N. E. (2019). Use of nanoparticles in tissue engineering and regenerative medicine. Frontiers in bioengineering and biotechnology, 7, 113.

Gavas, S., Quazi, S., & Karpiński, T. M. (2021). Nanoparticles for cancer therapy: current progress and challenges. Nanoscale research letters, 16(1), 173.

Gregory, A. E., Titball, R., & Williamson, D. (2013). Vaccine delivery using nanoparticles. Frontiers in cellular and infection microbiology, 3, 13.

Grunwald, P. (2020). Genome Editing and Gene Therapies: Complex and Expensive Drugs. In Pharmaceutical Biocatalysis (pp. 281-374). Jenny Stanford Publishing.

Gurunathan, S., Qasim, M., Choi, Y., Do, J. T., Park, C., Hong, K., ... & Song, H. (2020). Antiviral potential of nanoparticles—can nanoparticles fight against coronaviruses?. Nanomaterials, 10(9), 1645.

Hashem, N. M., & Gonzalez-Bulnes, A. (2020). State-of-the-art and prospective of nanotechnologies for smart reproductive management of farm animals. Animals, 10(5), 840.

Haverkamp, R. G., & Marshall, A. T. (2009). The mechanism of metal nanoparticle formation in plants: limits on accumulation. Journal of Nanoparticle Research, 11, 1453-1463.

Hosseini, M., & Mozafari, M. (2020). Cerium oxide nanoparticles: recent advances in tissue engineering. Materials, 13(14), 3072.

Ingersoll, K. S., & Cohen, J. (2008). The impact of medication regimen factors on adherence to chronic treatment: a review of the literature. Journal of Behavioral Medicine, 31, 213-224.

Kemp, J. A., & Kwon, Y. J. (2021). Cancer nanotechnology: current status and perspectives. Nano convergence, 8(1), 34.

Khan, F., Shahid, A., Zhu, H., Wang, N., Javed, M. R., Ahmad, N., ... & Mehmood, M. A. (2022). Prospects of algae-based green synthesis of nanoparticles for environmental applications. Chemosphere, 293, 133571.

Khan, F., Shahid, A., Zhu, H., Wang, N., Javed, M. R., Ahmad, N., ... & Mehmood, M. A. (2022). Prospects of algae-based green synthesis of nanoparticles for environmental applications. Chemosphere, 293, 133571.

Kim, B. H., Yang, J., Lee, D., Choi, B. K., Hyeon, T., & Park, J. (2018). Liquid‐phase transmission electron microscopy for studying colloidal inorganic nanoparticles. Advanced Materials, 30(4), 1703316.

Koul, B., Poonia, A. K., Yadav, D., & Jin, J. O. (2021). Microbe-mediated biosynthesis of nanoparticles: Applications and future prospects. Biomolecules, 11(6), 886.

Kumar, J. A., Krithiga, T., Manigandan, S., Sathish, S., Renita, A. A., Prakash, P., ... & Crispin, S. (2021). A focus to green synthesis of metal/metal based oxide nanoparticles: Various mechanisms and applications towards ecological approach. Journal of Cleaner Production, 324, 129198.

Li, X., Xu, H., Chen, Z. S., & Chen, G. (2011). Biosynthesis of nanoparticles by microorganisms and their applications. Journal of nanomaterials, 2011(1), 270974.

Lim, E. K., Kim, T., Paik, S., Haam, S., Huh, Y. M., & Lee, K. (2015). Nanomaterials for theranostics: recent advances and future challenges. Chemical Reviews, 115(1), 327-394.

Mao, Y., Park, T. J., Zhang, F., Zhou, H., & Wong, S. S. (2007). Environmentally friendly methodologies of nanostructure synthesis. Small, 3(7), 1122-1139.

Mattheolabakis, G., Rigas, B., & Constantinides, P. P. (2012). Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. Nanomedicine, 7(10), 1577-1590.

Mirza, Z., & Karim, S. (2021, February). Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges. In Seminars in cancer biology (Vol. 69, pp. 226-237). Academic Press.

Moritz, M., & Geszke-Moritz, M. (2013). The newest achievements in synthesis, immobilization and practical applications of antibacterial nanoparticles. Chemical Engineering Journal, 228, 596-613.

Nandhini, J., Karthikeyan, E., Rani, E. E., Karthikha, V. S., Sanjana, D. S., Jeevitha, H., ... & Priyadharshan, A. (2024). Advancing engineered approaches for sustainable wound regeneration and repair: Harnessing the potential of green synthesized silver nanoparticles. Engineered Regeneration, 5(3), 306-325.

Nisar, P., Ali, N., Rahman, L., Ali, M., & Shinwari, Z. K. (2019). Antimicrobial activities of biologically synthesized metal nanoparticles: an insight into the mechanism of action. JBIC Journal of Biological Inorganic Chemistry, 24, 929-941.

Ovais, M., Khalil, A. T., Islam, N. U., Ahmad, I., Ayaz, M., Saravanan, M., ... & Mukherjee, S. (2018). Role of plant phytochemicals and microbial enzymes in the biosynthesis of metallic nanoparticles. Applied microbiology and biotechnology, 102, 6799-6814.

Pala, R., Anju, V. T., Dyavaiah, M., Busi, S., & Nauli, S. M. (2020). Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. International journal of nanomedicine, 3741-3769.

Pandit, C., Roy, A., Ghotekar, S., Khusro, A., Islam, M. N., Emran, T. B., ... & Bradley, D. A. (2022). Biological agents for the synthesis of nanoparticles and their applications. Journal of King Saud University-Science, 34(3), 101869.

Patel, D. M., Patel, N. N., & Patel, J. K. (2021). Nanomedicine scale-up technologies: feasibilities and challenges. In Emerging Technologies for Nanoparticle Manufacturing (pp. 511-539). Cham: Springer International Publishing.

Pérez-Hernández, H., Pérez-Moreno, A., Sarabia-Castillo, C. R., García-Mayagoitia, S., Medina-Pérez, G., López-Valdez, F., ... & Fernández-Luqueño, F. (2021). Ecological drawbacks of nanomaterials produced on an industrial scale: collateral effect on human and environmental health. Water, Air, & Soil Pollution, 232, 1-33.

Rahdar, A., Amini, N., Askari, F., & Susan, M. A. B. H. (2019). Dynamic light scattering: A useful technique to characterize nanoparticles. Journal of Nanoanalysis, 6(2), 80-89.

Rónavári, A., Igaz, N., Adamecz, D. I., Szerencsés, B., Molnar, C., Kónya, Z., ... & Kiricsi, M. (2021). Green silver and gold nanoparticles: Biological synthesis approaches and potentials for biomedical applications. Molecules, 26(4), 844.

Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., ... & Gaspar, R. S. (2015). Regulatory aspects on nanomedicines. Biochemical and biophysical research communications, 468(3), 504-510.

Shafey, A. M. E. (2020). Green synthesis of metal and metal oxide nanoparticles from plant leaf extracts and their applications: A review. Green Processing and Synthesis, 9(1), 304-339.

Shankar, P. D., Shobana, S., Karuppusamy, I., Pugazhendhi, A., Ramkumar, V. S., Arvindnarayan, S., & Kumar, G. (2016). A review on the biosynthesis of metallic nanoparticles (gold and silver) using bio-components of microalgae: Formation mechanism and applications. Enzyme and Microbial Technology, 95, 28-44.

Stan, D., Enciu, A. M., Mateescu, A. L., Ion, A. C., Brezeanu, A. C., Stan, D., & Tanase, C. (2021). Natural compounds with antimicrobial and antiviral effects and nanocarriers are used for their transportation. Frontiers in pharmacology, 12, 723233.

Vargas-Estrada, L., Torres-Arellano, S., Longoria, A., Arias, D. M., Okoye, P. U., & Sebastian, P. J. (2020). Role of nanoparticles on microalgal cultivation: A review. Fuel, 280, 118598.

Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021). Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment. Advanced drug delivery reviews, 176, 113891.

Yadav, S. K., Lal, S., Yadav, S., Laxman, J., Verma, B., Sushma, M., ... & Sharma, V. (2019). Use of nanotechnology in agri-food sectors and apprehensions: an overview. Seed Res, 47(2), 99-149.

Yousaf, Z., & Saleh, N. (2018). Advanced concept of green synthesis of metallic nanoparticles by reducing phytochemicals. Nanobotany, 17-36.

Downloads

Published

2024-09-30

How to Cite

JANNAT , A., BALQEES , K., HASNAIN , M., ASHIQ , M., MUZAMMAL , F., JAVAID , Z., SAEED , Z., BAIG , M., MUMTAZ , T., & RAUF , U. (2024). BIOSYNTHESIZE NANOPARTICLES AS ADVANCED NANOCARRIERS FOR TARGETED THERAPEUTIC INTERVENTIONS IN DISEASE MANAGEMENT. Biological and Clinical Sciences Research Journal, 2024(1), 1152. https://doi.org/10.54112/bcsrj.v2024i1.1152

Most read articles by the same author(s)